CVR 45000621Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København NFounded 7 Aug 2024
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Glioray ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
2
CVR registry, Aug 2026
-2 (-50%) over 12 months
Gross profit
-904.2K
DKK, annual report 2025
Result
-1.4M
DKK, annual report 2025
Equity
-1.3M
DKK, annual report 2025
AIJ Holding 2020 ApSCVR 41307145, 25% to under 33.3% of capital and votes, since 7 Aug 2024
H. Thisgaard Holding ApSCVR 44914085, 25% to under 33.3% of capital and votes, since 7 Aug 2024
and 2 moreHelge Thisgaardsince 7 Aug 2024
Andreas Tue Ingemann Jensensince 7 Aug 2024
Bo Hallesince 7 Aug 2024
Equity was negative at 31 Dec 2025: -1.3M DKK. Dandex estimate, computed 5 Nov 2026.
CVR 2921147710% to under 15% of capital and votessince 4 Sep 2025
CVR 4130714525% to under 33.3% of capital and votesnotified 4 Sep 2025since 7 Aug 2024
CVR 4491408525% to under 33.3% of capital and votesnotified 4 Sep 2025since 7 Aug 2024
CVR 4492351325% to under 33.3% of capital and votesnotified 4 Sep 2025since 7 Aug 2024
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
7 Aug 2024 to 5 Nov 2026.
Aug 2026, monthly: 2 employees, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 2 |
| FTE | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 0 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Sep 2024 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2025 |
|---|---|
| Gross profit | -904 |
| Operating profit | -1,439 |
| Result for the year | -1,376 |
| Equity | -1,331 |
| Total assets | 3,564 |
| Employees (average) | 2 |
| Credit metrics (Dandex calculations) | |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -1,700note 1 |
| Capex (investeringer i anlægsaktiver) | 1,461note 2 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. 2025 covers 17 months (7 Aug 2024 to 31 Dec 2025).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
7 Aug 2024 to 31 Dec 2025, published 4 Jun 2026
Each registered value from the day it took effect, newest first.
From CVR, read 5 Nov 2026. Text such as the signing rule and purpose is shown as registered.
4 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 04.09.2025
Kapitalforhøjelsen er besluttet den 04.09.2025.
kr. 4.445,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 44.447,00.
Bestyrelse:
Tiltrådte:
Lene Nielsen, den 04.09.2025.
Vedtægter ændret: 19.06.2025
Binavne: Glioray Therapeutics ApS.
Stiftelsesdato: 07.08.2024.
Virkningsdato: 07.08.2024.
Seneste vedtægtsdato: 07.08.2024.
Kapital:
kr. 40.002,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.002,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 41307145 AIJ Holding 2020 ApS, Engbakken 40, 2830 Virum, den 07.08.2024, CVR-NR. 44914085 H. Thisgaard Holding ApS, Rømøvænget 99, 5500 Middelfart, den 07.08.2024, CVR-NR. 44923513 Halle Holdings ApS, Rikkeshave 3, Dalum, 5250 Odense SV, den 07.08.2024.
Bestyrelse:
Bo Halle, den 07.08.2024, Chief Executive Officer Andreas Tue Ingemann Jensen, den 07.08.2024, Helge Thisgaard, den 07.08.2024.
Direktion:
Bo Halle, den 07.08.2024, Chief Executive Officer Andreas Tue Ingemann Jensen, den 07.08.2024, Helge Thisgaard, den 07.08.2024.
Selskabet tegnes af to bestyrelsesmedlemmer i forening
Første regnskabsår:
07.08.2024 - 31.12.2025.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er forskning- og udviklingsaktiviteter inden for lægemiddelindustrien, især indenfor den radiofarmaceutiske industri, samt al virksomhed som efter ledelsens skøn har forbindelse hermed.
1 registered in CVR.
P-number 1030571092Ole Maaløes Vej 3, 2200 København N
No other current company drawn.
